IQV vs WAT
IQVIA and Waters Corporation, both Healthcare
IQVIA is the larger company at $43B against $42B. On trailing earnings IQV is the cheaper of the two at a P/E of 32.5 against 107.8, a gap that is only a bargain if the two are growing at similar rates. Over the past year WAT returned +44% against +40% for IQV. The RyuScore puts IQV ahead, 66 against 49 out of 100.
| Figure | IQV | WAT |
|---|---|---|
| Last close | $262 | $432 |
| Market cap | $43B | $42B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 32.5 | 107.8 |
| 1-year return | +40% | +44% |
| 5-year return | +1.8% | +5.6% |
| RyuScoresector-relative, 1–10 | 66/100 | 49/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
IQVIA
Revenue of $4.2B in Q1 2026, net income $274M. Its largest reported line is Research And Development Solutions, 56% of the disclosed total.
Waters Corporation
Revenue of $1.6B in Q2 2026, net income null. Its largest reported line is Consumables, 47% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.